fashion -WSS

fashion

author：focus 2025-10-01 11:02:07 - browse：4214

Sen. Elizabeth Warren gestures with one hand during a hearing — insurance coverage from STAT — Sen. Elizabeth Warren (D-Mass.) Kent Nishimura/Getty Images

Senate Democrats on Thursday said Medicare should take more urgent and aggressive action to prevent health insurance companies from using artificial intelligence to unlawfully deny medical services.

The Biden administration’s latest efforts to increase transparency into AI tools don’t go far enough to protect patients, the lawmakers said at a Senate Finance Committee hearing.

Sen. Elizabeth Warren (D-Mass.), citing a STAT investigation, took particularly sharp aim at the use of algorithms to deny care within Medicare Advantage. STAT’s stories had found repeated denials of desperately ill patients by the nation’s largest insurers.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： George Santos makes 1st court appearance after pleading not guilty to 13 counts
Next article： Biotech lab space demand falls sharply

entertainment

WSS

Boston's new lab space is opening empty

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

Why are Kaiser Permanente staff considering a strike?

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

How many hemophilia patients actually want gene therapy?

Biotech lab space demand falls sharply

entertainment

fashion

knowledge

State Dept. review finds Biden bears some blame for Afghanistan failures

Experts study whether long Covid risk adds up with each reinfection

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Hearing on Medicare drug price negotiation gets unusually heated

Medicare details structure of new drug price negotiation program

How many hemophilia patients actually want gene therapy?

United colonoscopy coverage change 'may cost lives,' doctors say

Boston's new lab space is opening empty

knowledge

As AI in medicine takes off, can 'human in the loop' prevent harm?

Amid AI frenzy, a top HHS official's quest to create safeguards

Ebola: Gilead Sciences antiviral shows promise as new treatment

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

Emergency workers more likely to restrain Black patients: study

focus

entertainment

focus

Wikipedia